haha the first basher is ALREADY posting that this is
haha the first basher is ALREADY posting that this is desperation and meaningless. Double LOL
By the way, my theory is that they have not revealed what country the test is taking place in because they are well aware that some hedge funds hire investigators to try to figure out how clinical trials are going, and don't want to give out information that could help these creeps.
There have been reports about OTHER clinical trials that some doctors and nurses have admitted to being paid by funds to give their impressions of whether patients are making progress. Also investigators can monitor Facebook posts etc for people posting about feeling better. This happened with HEB's drug. It would be pretty easy for someone to figure out whether the Bril-OM patients are doing well.
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...
Continue Reading
Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...
Continue Reading
Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...
Continue Reading
A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...
Continue Reading
Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....
Continue Reading
A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...
Continue Reading
A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...
Continue Reading
Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...
Continue Reading
By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...
Continue Reading
Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...
Continue Reading
Top 5 Most Recently Viewed Articles
Hippo's Remarkable Financial Performance in Q3 2024 Hippo (NYSE: HIPO), a leader in home insurance dedicated to proactive protection, has unveiled its financial highlights for the third quarter of 2024. This announcement celebrates a continuation of their success, driven by strategic initiatives aimed at achieving profitable growth. Strong Revenue Growth Hippo reported...
Continue Reading
Alloy Personal Training Partners with CapitalSpring for Expansion Alloy Personal Training recently announced an innovative collaboration with a reputable investment firm to boost its franchise growth and reach across the nation. This strategic partnership marks a notable chapter in the company’s history, reinforcing its commitment to a people-centric business model...
Continue Reading
Intel's Long-Term Commitment to Foundry Services Intel Corp (NASDAQ: INTC) has recently shared its strategic vision with employees, highlighting a gradual approach to growth instead of seeking quick profits. Analysts report that while there may not be any revolutionary announcements on the horizon, Intel's plans and intentions are coming into clearer focus. Analyst Harlan...
Continue Reading
Earned Media: The Overlooked Goldmine South Florida's advertising scene is a bit like a crowded beach with everyone scrambling for the same spot of sand. But Good At Marketing, based in Boynton Beach, is wading in deeper waters. They've cracked the code to something their competition hasn't even considered: earned media. Not your basic ad buy, this agency says earned...
Continue Reading
Zevra Therapeutics Reports Strong Financial Results for 2024 In a significant step forward, Zevra Therapeutics, Inc. (NASDAQ: ZVRA) has released its financial results for the full year of 2024, reporting impressive net revenues of $23.6 million. This figure includes remarkable fourth-quarter contributions, with net revenue reaching $12.0 million. Company's Strategic Moves...
Continue Reading